Filtros de búsqueda

Lista de obras de

115Comparison of Emerging Infections Program (EIP) and National Healthcare Safety Network (NHSN) Datasets for Surveillance of Methicillin-Resistant Staphylococcus aureus (MRSA) and Clostridium difficile Infection (CDI).

artículo científico publicado en 2014

1162. Epidemiology of Carbapenem-Resistant Pseudomonas aeruginosa Identified Through the Emerging Infections Program (EIP), United States, 2016–2017

article published in 2018

1639A Tale of Two States: An Exploration of Disparities in the Proportion of Long-term Care Facility–onset Clostridium difficile Infections in Minnesota and New Mexico

artículo científico publicado en 2014

1722. The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Emerging Risk Factor for Candidemia

1761. Effect of Carbapenem-Resistant Enterobacteriaceae (CRE) Surveillance Case Definition Change on CRE Epidemiology—Selected US Sites, 2015–2016

1800Phenotypic Definitions for Identifying Carbapenemase-Producing Carbapenem-resistant Enterobacteriaceae

artículo científico publicado en 2014

482. Association between Socioeconomic Status Factors and Incidence of Community-Associated Clostridium difficile Infection Utilizing Factor Analysis—United States, 2014–2015

scholarly article by Kimberly Skrobarcek et al published November 2018 in Open Forum Infectious Diseases

486. Epidemiology of Carbapenem-Resistant Pseudomonas aeruginosa Identified through the Emerging Infections Program (EIP), United States, 2016–2018

490. Comparison of Clostridium difficile Infection Outcomes by Diagnostic Testing Method

492. Long-Term Outcomes of Clostridium difficile Infection Among Medicare Beneficiaries

507. Epidemiology of Community-Associated Carbapenemase + Producing Carbapenem-Resistant Enterobacteriacae Identified from the Emerging Infections Program, 2012–2017

524National estimates of incidence, recurrence, hospitalization, and death of nursing home-onset infections — United States, 2012

538. Extended-Spectrum β-Lactamase (ESBL): Producing Enterobacteriaceae Surveillance Pilot, New Mexico, 2017

837. Prior Hospitalizations Among Cases of Community-Associated Clostridioides difficile Infection—10 US States, 2014–2015

artículo científico publicado en 2019

Association Between Outpatient Antibiotic Prescribing Practices and Community-Associated Clostridium difficile Infection

artículo científico publicado en 2015

Burden of Candidemia in the United States, 2017

artículo científico publicado en 2020

Burden of Clostridium difficile infection in the United States

artículo científico publicado en 2015

Burden of Nursing Home-Onset Clostridium difficile Infection in the United States: Estimates of Incidence and Patient Outcomes

artículo científico publicado en 2016

Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012-2015.

artículo científico publicado en 2018

Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015

scientific article published on 01 July 2019

Clostridium difficile infection among children across diverse US geographic locations

artículo científico publicado en 2014

Differences in Clinical Characteristics and Outcomes of Patients with Community-Onset Clostridium difficile Infection who Tested Positive by EIA Compared with NAAT through a Two-Step Algorithm

artículo científico publicado en 2017

Disparities in the incidence of community-acquired Clostridioides difficile infection: An area-based assessment of the role of social determinants in Bernalillo County, New Mexico

artículo científico publicado en 2019

Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013.

artículo científico publicado en 2015

Impact of changes in Clostridium difficile testing practices on stool rejection policies and C. difficile positivity rates across multiple laboratories in the United States

artículo científico publicado en 2013

Improved Phenotype-Based Definition for Identifying Carbapenemase Producers among Carbapenem-Resistant Enterobacteriaceae

artículo científico publicado en 2015

Molecular Characterization of Carbapenem-Resistant Enterobacteriaceae in the USA, 2011–2015.

artículo científico publicado en 2017

NAP1 strain type predicts outcomes from Clostridium difficile infection

artículo científico publicado en 2014

Risk Factors for Community-Associated Clostridium difficile Infection in Adults: A Case-Control Study.

artículo científico publicado en 2017

Socioeconomic Status Factors Associated with Increased Incidence of Community-Associated Clostridium difficile Infection

artículo científico publicado en 2017

The AVMA's definitions of antimicrobial uses for prevention, control, and treatment of disease

artículo científico publicado en 2019

The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Increasingly Common Risk Factor - Active Surveillance in Selected Sites, United States, 2014-17

scientific article published on 02 November 2019

Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection with Greater Severity and Higher Recurrence Rates

artículo científico publicado en 2019

Treatment of Clostridioides difficile Infection and Non-compliance with Treatment Guidelines in Adults in 10 US Geographical Locations, 2013-2015

scientific article published on 25 November 2019

Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes

artículo científico publicado en 2020

Trends in incidence of long-term-care facility onset Clostridium difficile infections in 10 US geographic locations during 2011-2015.

artículo científico publicado en 2018

Wide Range of Carbapenem-resistant Enterobacteriaceae Incidence and Trends in Emerging Infections Program Surveillance, 2012–2015.

artículo científico publicado en 2017

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda